Sean Dodge
Stock Analyst at BMO Capital
(0.26)
# 4,477
Out of 4,676 analysts
504
Total ratings
43.9%
Success rate
-3.5%
Average return
Main Sectors:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVAH Aveanna Healthcare Holdings | Reiterated: Buy | $10 → $14 | $13.59 | +3.02% | 4 | Aug 14, 2026 | |
| PRVA Privia Health Group | Maintained: Buy | $30 | $21.20 | +41.51% | 18 | Aug 7, 2026 | |
| EVH Evolent Health | Maintained: Buy | $6 | $4.89 | +22.70% | 54 | Aug 6, 2026 | |
| SHC Sotera Health Company | Rated: Buy | $20 → $22 | $19.51 | +12.76% | 29 | Aug 6, 2026 | |
| LFST LifeStance Health Group | Rated: Buy | $11 → $13 | $12.28 | +5.86% | 5 | Aug 6, 2026 | |
| DOCS Doximity | Rated: Hold | $20 → $30 | $24.74 | +21.26% | 4 | Aug 6, 2026 | |
| OMDA Omada Health | Rated: Buy | $20 → $24 | $23.94 | +0.25% | 4 | Aug 6, 2026 | |
| MDLN Medline | Rated: Buy | $54 → $47 | $35.64 | +31.87% | 3 | Aug 5, 2026 | |
| ADUS Addus HomeCare | Maintained: Hold | $110 → $115 | $121.09 | -5.03% | 5 | Aug 4, 2026 | |
| CERT Certara | Maintained: Hold | $6 → $8 | $8.14 | -1.72% | 4 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $57.23 | +22.31% | 6 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 → $270 | $259.42 | +4.08% | 14 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $7 | $6.19 | +13.09% | 56 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 | $24.21 | +23.92% | 12 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $600 | $614.06 | -2.29% | 5 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 | $22.94 | +4.62% | 54 | Jul 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $160 → $187 | $168.91 | +10.71% | 9 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $11.52 | +21.53% | 31 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $220 → $175 | $246.78 | -29.09% | 4 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $85 → $105 | $105.39 | -0.37% | 33 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $3.48 | n/a | 30 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $6 | $1.58 | n/a | 22 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $3.5 | $96.11 | n/a | 18 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 → $6 | $7.86 | n/a | 23 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $4.80 | n/a | 30 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 | $0.0001 | n/a | 13 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $7.10 | n/a | 1 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8.5 → $7 | $1.16 | n/a | 11 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $135 | $234.19 | n/a | 1 | May 19, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $905.09 | n/a | 1 | Aug 2, 2010 |
Aveanna Healthcare Holdings
Aug 14, 2026
Reiterated: Buy
Price Target: $10 → $14
Current: $13.59
Upside: +3.02%
Privia Health Group
Aug 7, 2026
Maintained: Buy
Price Target: $30
Current: $21.20
Upside: +41.51%
Evolent Health
Aug 6, 2026
Maintained: Buy
Price Target: $6
Current: $4.89
Upside: +22.70%
Sotera Health Company
Aug 6, 2026
Rated: Buy
Price Target: $20 → $22
Current: $19.51
Upside: +12.76%
LifeStance Health Group
Aug 6, 2026
Rated: Buy
Price Target: $11 → $13
Current: $12.28
Upside: +5.86%
Doximity
Aug 6, 2026
Rated: Hold
Price Target: $20 → $30
Current: $24.74
Upside: +21.26%
Omada Health
Aug 6, 2026
Rated: Buy
Price Target: $20 → $24
Current: $23.94
Upside: +0.25%
Medline
Aug 5, 2026
Rated: Buy
Price Target: $54 → $47
Current: $35.64
Upside: +31.87%
Addus HomeCare
Aug 4, 2026
Maintained: Hold
Price Target: $110 → $115
Current: $121.09
Upside: -5.03%
Certara
Aug 4, 2026
Maintained: Hold
Price Target: $6 → $8
Current: $8.14
Upside: -1.72%
Aug 3, 2026
Maintained: Buy
Price Target: $70
Current: $57.23
Upside: +22.31%
Jul 29, 2026
Maintained: Buy
Price Target: $210 → $270
Current: $259.42
Upside: +4.08%
Jul 29, 2026
Rated: Hold
Price Target: $5 → $7
Current: $6.19
Upside: +13.09%
Jul 29, 2026
Rated: Buy
Price Target: $30
Current: $24.21
Upside: +23.92%
Jul 27, 2026
Maintained: Hold
Price Target: $600
Current: $614.06
Upside: -2.29%
Jul 22, 2026
Reiterated: Hold
Price Target: $24
Current: $22.94
Upside: +4.62%
Jun 25, 2026
Maintained: Buy
Price Target: $160 → $187
Current: $168.91
Upside: +10.71%
Jun 22, 2026
Maintained: Buy
Price Target: $14
Current: $11.52
Upside: +21.53%
Jun 3, 2026
Maintained: Hold
Price Target: $220 → $175
Current: $246.78
Upside: -29.09%
Apr 9, 2026
Upgraded: Buy
Price Target: $85 → $105
Current: $105.39
Upside: -0.37%
Feb 27, 2025
Maintained: Buy
Price Target: $6
Current: $3.48
Upside: n/a
Feb 26, 2025
Maintained: Hold
Price Target: $7 → $6
Current: $1.58
Upside: n/a
Feb 25, 2025
Maintained: Buy
Price Target: $3 → $3.5
Current: $96.11
Upside: n/a
Jan 8, 2025
Downgraded: Hold
Price Target: $7 → $6
Current: $7.86
Upside: n/a
Mar 13, 2024
Maintained: Buy
Price Target: $11
Current: $4.80
Upside: n/a
May 11, 2022
Maintained: Hold
Price Target: $2
Current: $0.0001
Upside: n/a
Nov 10, 2021
Reiterated: Buy
Price Target: $16
Current: $7.10
Upside: n/a
Feb 20, 2019
Reiterated: Hold
Price Target: $8.5 → $7
Current: $1.16
Upside: n/a
May 19, 2017
Reiterated: Sell
Price Target: $135
Current: $234.19
Upside: n/a
Aug 2, 2010
Reiterated: Buy
Price Target: n/a
Current: $905.09
Upside: n/a